Cardiac Injury After Traumatic Brain Injury: Clinical Consequences and Management
- 28 June 2023
- journal article
- research article
- Published by Springer Nature in Neurocritical Care
- Vol. 40 (2) , 1-9
Abstract
Traumatic brain injury (TBI) is a significant public health issue because of its increasing incidence and the substantial short-term and long-term burden it imposes. This burden includes high mortality rates, morbidity, and a significant impact on productivity and quality of life for survivors. During the management of TBI, extracranial complications commonly arise during the patient’s stay in the intensive care unit. These complications can have an impact on both mortality and the neurological outcome of patients with TBI. Among these extracranial complications, cardiac injury is a relatively frequent occurrence, affecting approximately 25–35% of patients with TBI. The pathophysiology underlying cardiac injury in TBI involves the intricate interplay between the brain and the heart. Acute brain injury triggers a systemic inflammatory response and a surge of catecholamines, leading to the release of neurotransmitters and cytokines. These substances have detrimental effects on the brain and peripheral organs, creating a vicious cycle that exacerbates brain damage and cellular dysfunction. The most common manifestation of cardiac injury in TBI is corrected QT (QTc) prolongation and supraventricular arrhythmias, with a prevalence up to 5 to 10 times higher than in the general adult population. Other forms of cardiac injury, such as regional wall motion alteration, troponin elevation, myocardial stunning, or Takotsubo cardiomyopathy, have also been described. In this context, the use of β-blockers has shown potential benefits by intervening in this maladaptive process. β-blockers can limit the pathological effects on cardiac rhythm, blood circulation, and cerebral metabolism. They may also mitigate metabolic acidosis and potentially contribute to improved cerebral perfusion. However, further clinical studies are needed to elucidate the role of new therapeutic strategies in limiting cardiac dysfunction in patients with severe TBI.Keywords
This publication has 74 references indexed in Scilit:
- Beta Blockers for Acute Traumatic Brain Injury: A Systematic Review and Meta-analysisNeurocritical Care, 2013
- Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury: Clinical and Prognostic ImplicationsJournal of Neurotrauma, 2012
- Oestrogen upregulates L‐type Ca2+channels via oestrogen‐receptor‐α by a regional genomic mechanism in female rabbit heartsThe Journal of Physiology, 2012
- Critical care management of severe traumatic brain injury in adultsScandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2012
- Treating critical supraventricular and ventricular arrhythmiasJournal of Emergencies, Trauma, and Shock, 2010
- Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhageNeurology, 2009
- Significance of Troponin Elevation After Severe Traumatic Brain InjuryJournal of Trauma: Injury, Infection & Critical Care, 2008
- Determinants of Long-Term Functional Consequences After Major TraumaJournal of Trauma: Injury, Infection & Critical Care, 2007
- Electrocardiographic abnormalities associated with raised intracranial pressure.BMJ, 1975
- Effects of Barbiturates on Pulmonary and Systemic HaemodynamicsCardiovascular Research, 1968